Loading
Life sciences · Journal article
Advanced Science · October 29, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Energy homeostasis requires integration of metabolic and stress signals within hypothalamic circuits, yet the role of neuronal proteostasis remains unclear. Ubiquitin protein ligase E3A (UBE3A) regulates the stability of lysine demethylase 6A (KDM6A), also known as ubiquitously transcribed tetratricopeptide repeat containing, X chromosome (UTX). Hypothalamic neuronal deletion of Ube3a results in hyperphagia, obesity, hyperleptinemia, and impaired glucose homeostasis under high-fat diet conditions; selective deletion in agouti-related peptide (AgRP) neurons is sufficient to recapitulate these phenotypes. UBE3A promotes UTX degradation, whereas UBE3A loss stabilizes UTX and decreases repressive histone H3 lysine 27 trimethylation (H3K27me3). Integrated transcriptomic and epigenomic analyses implicate UTX and activating transcription factor 4 (ATF4) in altered endoplasmic reticulum (ER) stress-responsive transcriptional programs, although their causal contribution to the metabolic phenotype remains to be established. Treatment with GSK-J4, an inhibitor of KDM6-family demethylases, increases hypothalamic H3K27me3 levels and improves metabolic outcomes in Ube3a-deficient mice, although the specific contribution of hypothalamic UTX inhibition to these effects remains to be established. These findings support a link between neuronal proteostasis, chromatin regulation, and systemic metabolic homeostasis and warrant further investigation of the relevance of UTX-associated pathways to metabolic dysfunction in a subset of individuals with Angelman syndrome.